Current status of percutaneous PFO closure.

Journal Article (Review)

The clinical significance of persistent patent foramen ovale (PFO) is not well defined. Empirically, PFO has been associated with many clinical conditions. In cryptogenic stroke, migraine, and orthodeoxia/platypnea, a plausible biologic mechanism exists to support PFO closure as a possible treatment. Although transcatheter closure of PFO has been available for over 2 decades, it has remained controversial due to a paucity of evidence to guide patient and device selection. Contemporary studies investigating PFO closure as treatment for patients with these conditions have been published recently and longitudinal data regarding the safety and efficacy of the devices is now available. In this review, we aim to describe the potential clinical significance of a patent foramen in the adult, appraise the newest additions to the body of evidence, and discuss the safety, benefit, patient selection, and future of transcatheter treatment of PFO.

Full Text

Duke Authors

Cited Authors

  • Rohrhoff, N; Vavalle, JP; Halim, S; Kiefer, TL; Harrison, JK

Published Date

  • May 2014

Published In

Volume / Issue

  • 16 / 5

Start / End Page

  • 477 -

PubMed ID

  • 24633647

Electronic International Standard Serial Number (EISSN)

  • 1534-3170

International Standard Serial Number (ISSN)

  • 1523-3782

Digital Object Identifier (DOI)

  • 10.1007/s11886-014-0477-4

Language

  • eng